All in all, the standard of care regarding ALK TKIs for ALK rearranged NSCLC is rapidly evolving with the elucidation of the complexity, for example, resistance mechanisms, efficacy, CNS-penetrance of various ALK TKIs. The gene discussed is ALK; the disease is non-small cell lung carcinoma.